Mete Ercis

For patients with #FirstEpisodePsychosis unresponsive to initial antipsychotic therapy, clozapine improved symptom response rates and reduced discontinuation due to insufficient efficacy vs olanzapine or amisulpride. ja.ma/4uodHeC

Excited about our latest publication in Bipolar Disorders! 🎉 SGLT2 inhibitors were associated with improved kidney function trajectories in lithium-treated patients 💊📈 Grateful to @MayoPsych, @BalSinghMD & all collaborators. 🔗 onlinelibrary.wiley.com/share/author/D…

Osman Kavala 3 bin gündür cezaevinde birgun.net/haber/osman-ka…

RIP Stack Overflow.

After 5 yrs of data collection, our WARN-D machine learning competition to forecast depression onset is now LIVE! We hope many of you will participate. If you share a single thing of my lab this year, please make it this competition. eiko-fried.com/warn-d-machine…

New publication in @ActaPsychScand: "Seasonality Patterns in Bipolar Disorder: Associations With Clinical Phenotypes and Treatment-Related Outcomes" #Bipolardisorder onlinelibrary.wiley.com/doi/10.1111/ac…

Ruşen Çakır: "Şiirle bir ilginiz varsa Ahmet Güntan’ı muhakkak okuyun."

@MayoPsych Free full-text access here 👇 authors.elsevier.com/c/1m8MR55vZHUW9

📢 Our new systematic review & meta-analysis is out! Across 50 studies, we examined the prevalence of dermatologic side effects 📊 of mood stabilizers 💊 in bipolar disorder. @MayoPsych 🔍 Full text: doi.org/10.1016/j.jpsy…

The Naroditsky family shares the sad news of Daniel’s unexpected passing. Daniel was a talented chess player, educator, and beloved member of the chess community. We ask for privacy as the family grieves.

Balwinder Singh, MD, MS, @BalSinghMD presented his collaborative work, "Sodium-glucose Cotransporter 2 inhibitors for Lithium-Associated Kidney Dysfunction in Mood Disorders: A Historical Cohort Proof-of-Concept Study" at #ISBD2025 @ISBD4 #Lithium #MoodDisorders

@MayoPsych @BalSinghMD @ISBD4 For preprint of this work: doi.org/10.1101/2025.0…

🔍 New in @TheLancet: A Comprehensive Update on #BipolarDisorder Led by BD² investigator @BalSinghMD, this is a must-read for those working to improve outcomes for individuals with #bipolar disorder. 📖 Read the paper: authors.elsevier.com/a/1lTurV-4XShJF ▶️ Hear from @BalSinghMD:

Check out our new Seminar on bipolar disorder in @TheLancet. It was wonderful to work with these co-authors, led by Balwinder Singh. authors.elsevier.com/a/1lTurV-4XShJF

Defining Health Care “Corporatization” | New England Journal of Medicine nejm.org/doi/full/10.10…

In the first Perspective of a new series, Erin C. Fuse Brown, JD, MPH (@efusebrown), writes that “corporatization” of health care, a process predicted decades ago, now refers to the general trend throughout the industry toward higher levels of integrated control by consolidated profit-seeking enterprises. Learn more: nej.md/40rEOYH

For the International #LGBT Pride Day 🌈 have a look at the case series from @nurneyal @MayoClinic on gender-affirming interventions and prognosis in #MultipleSclerosis. 🔽 journals.sagepub.com/doi/full/10.11… 1/🧵

3/ I'm grateful to my close collaborator Alessandro Miola, our dedicated team at @MayoPsych, and my mentors @AysegulOzerdem and Mark Frye. I also want to thank my residency mentor @alpucok, who taught me the importance of early intervention and inspired my passion.🌟

2/ Our findings support a transdiagnostic framework for more precise, tailored early interventions in mental health—guided by each subgroup’s unique trajectory. 🎯🧠✨

Are there unique pathways leading to a first episode of mania or psychosis? 🔍 Using latent class analysis, we identified 3 distinct antecedent trajectories. 📄PDF: onlinelibrary.wiley.com/share/author/U… 🔗Link: doi.org/10.1111/acps.1… 👇